Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials.
| Image |  |
|---|---|
| Description | scientific article published on 19 April 2018 |
| Author/s |
author: Olivier Fitoussi Richard Delarue Corinne Haioun Sergei Syrbu James R Cerhan George J Weiner Brian K Link Susan L Slager Thierry J Molina Carrie A Thompson Umar Farooq Gilles Salles Cristine Allmer |
| Publication date | April 19, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |